Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Zhong Yao Cai ; 33(1): 89-92, 2010 Jan.
Artículo en Chino | MEDLINE | ID: mdl-20518313

RESUMEN

OBJECTIVE: To research the effects of Panax notoginseng saponins (PNS) on angiotensin-converting enzymes 2 ( ACE2) and tumor necrosis factor-alpha (TNF-alpha) in rats with post-myocardial infarction ventricular remodeling. METHODS: Models of acute myocardial infarction (AMI) were produced by ligation of left anterior descending coronary artery, 24 hours after operation the rats were randomly divided into control and experiment groups, then respectively administrated with NS, fosinopril and low, middle and high dosage of PNS for four consecutive weeks. To observe effects of PNS on malondialdehyde (MDA), nitric oxide (NO), glutathione peroxidase (GSH-Px), ACE2 and TNF-alpha in rats with post-myocardial infarction ventricular remodeling. RESULTS: Compared with NS group, MDA significantly decreased, the activity of GSH-Px significantly increased (P < 0.05 or P < 0.01), NO of the high-dose PNS group decreased (P < 0.05), Compared with the NS group, ACE2 increased and TNF-a significantly decreased in low-dose PNS group, middle and high-dose groups (P < 0.05). CONCLUSION: PNS can stimulate ACE2 to inhibit the expression of TNF-alpha and enhance the antioxidance. PNS can reduce pathological injury of cardiac myocytes in myocardial ischemia and cardiac muscle, which can improve ventricular remodeling.


Asunto(s)
Antioxidantes/farmacología , Infarto del Miocardio/tratamiento farmacológico , Peptidil-Dipeptidasa A/sangre , Saponinas/farmacología , Factor de Necrosis Tumoral alfa/sangre , Remodelación Ventricular/efectos de los fármacos , Enzima Convertidora de Angiotensina 2 , Animales , Modelos Animales de Enfermedad , Femenino , Fosinopril/farmacología , Glutatión Peroxidasa/sangre , Glutatión Peroxidasa/metabolismo , Masculino , Malondialdehído/sangre , Malondialdehído/metabolismo , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Óxido Nítrico/sangre , Óxido Nítrico/metabolismo , Panax notoginseng/química , Peptidil-Dipeptidasa A/metabolismo , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/metabolismo
2.
Zhong Yao Cai ; 33(10): 1592-5, 2010 Oct.
Artículo en Chino | MEDLINE | ID: mdl-21355198

RESUMEN

OBJECTIVE: To research the effects of Erigeron breviscapus injection (EBI) on TNF-alpha, PAI-1 and tPA in rats with acute myocardial infarction. METHODS: Models of acute myocardial infarction (AMI)were produced by ligation of left anterior descending coronary artery, then rats were randomly divided into control and experimental groups, then respectively gavaged NS, and the low, middle and high dosage of EBI for one week. The cardiac function index and the expression of TNF-alpha, tPA and PAI-1 were measured. RESULTS: Compared with the NS group, the cardiac function LVEDP, MAP, LVPmax, +/- dp/dt of AMI rat was improved by EBI in all dosage range, and the expression of TNF-alpha and PAI-1, LVEDP were decreased (P < 0.05), the expression of tPA, MAP, LVPmax and +/- dp/dt were increased obviously (P < 0.05) and had a dose-effect relationship. CONCLUSION: EBI can inhibit the expression of TNF-alpha and PAI-1, increase the expression of tPA,which can prevent the ongoing thrombopoiesis after AMI and improve the cardiac function. This maybe attributes to the inhibition of the overexpression of TNF-alpha.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Erigeron , Infarto del Miocardio/tratamiento farmacológico , Miocardio/metabolismo , Inhibidor 1 de Activador Plasminogénico/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Enfermedad Aguda , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/uso terapéutico , Erigeron/química , Inyecciones , Masculino , Infarto del Miocardio/etiología , Infarto del Miocardio/fisiopatología , Miocardio/patología , Inhibidor 1 de Activador Plasminogénico/sangre , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Activador de Tejido Plasminógeno/sangre , Activador de Tejido Plasminógeno/metabolismo , Factor de Necrosis Tumoral alfa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA